Skip to contentB
Bio-Path Holdings, Inc.
B
BPTHBio-Path Holdings, Inc. Q1 2013 · 10-Q
Revenue$0.00$0.00— vs Q1 2012 Net Income-$656.00K-$656.00KN/M vs Q1 2012 EPS Diluted-$0.01-$0.01N/M vs Q1 2012 Operating Income-$655,910N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bio-Path Holdings, Inc. · CIK 1133818 · Engraved from SEC EDGAR
ended Mar 31, 2013 · filed May 15, 2013 · 45 d after period end